This Blog,its owner,creator & contributor is neither a research analyst nor an Investment Advisor and expressing opinion only as an Investor in Indian equities.He/She is not responsible for any loss arising out of any information,post or opinion appearing on this blog.Investors are advised to do own due diligence and/or consult financial consultant before acting on any such information.Author of this blog not providing any paid service and not sending bulk mails/SMS to anyone.
Recently discussed the current situation of
Wockhardt in detail .Due to pending USFDA decision, better to avoid buying this
stock in single lot.Buy only 30% of the desired qty now and wait with patience
.If USFDA decision is negative ,one may get betteropportunity to buy more either at the time of
announcement or at the time of declaration of the quarterly result post
implementation of decision